Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nergis Akay

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
The Journal of Rheumatology|August 1, 2024
Children With Type I Interferonopathy: Commonalities and Diversities in a Large Patient CohortFatih Haslak, Huseyin Kilic, Sezgin Sahin, et al.
Pediatric Rheumatology Online Journal|June 19, 2026
Tumor necrosis factor inhibitor-related autoimmune disorders in pediatric rheumatology practice: a multicenter nationwide studyDeniz Gezgin Yıldırım, Batuhan Küçükali, Nergis Akay, et al.
Rheumatology (Oxford, England)|July 14, 2026
Effectiveness and probability of full disease control with canakinumab in familial Mediterranean fever: real-world data from the AIDA NetworkAntonio Vitale, Valeria Caggiano, Jessica Sbalchiero, et al.
Seminars in Arthritis and Rheumatism|June 27, 2026
Long-term remission and monocyclic course in Still's disease patients starting canakinumab early: data from the international AIDA network registryAntonio Vitale, Valeria Caggiano, Jessica Sbalchiero, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
The Journal of Rheumatology|August 1, 2024
Children With Type I Interferonopathy: Commonalities and Diversities in a Large Patient CohortFatih Haslak, Huseyin Kilic, Sezgin Sahin, et al.
Pediatric Rheumatology Online Journal|June 19, 2026
Tumor necrosis factor inhibitor-related autoimmune disorders in pediatric rheumatology practice: a multicenter nationwide studyDeniz Gezgin Yıldırım, Batuhan Küçükali, Nergis Akay, et al.
Rheumatology (Oxford, England)|July 14, 2026
Effectiveness and probability of full disease control with canakinumab in familial Mediterranean fever: real-world data from the AIDA NetworkAntonio Vitale, Valeria Caggiano, Jessica Sbalchiero, et al.
Seminars in Arthritis and Rheumatism|June 27, 2026
Long-term remission and monocyclic course in Still's disease patients starting canakinumab early: data from the international AIDA network registryAntonio Vitale, Valeria Caggiano, Jessica Sbalchiero, et al.
Pageof 3